HAL (France)
open access
Lecanemab for early Alzheimer's disease: Appropriate use recommendations from the French federation of memory clinics
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Safety and Efficacy Study Evaluating Dimebon (Latrepirdine) in Patients With Moderate to Severe Alzheimer's Disease#856648
- Intersection Of Capacity Law And Neurodegenerative Disease With A Focus On Alzheimer’s Medication#401534
- What can artificial intelligence bring to Alzheimer’s disease clinical trials? A first perspective#161340
- Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - TNFi vs Abatacept#895951
- An Open-Label Crenezumab Study in Participants With Alzheimer's Disease#1162908
Record · ID 161197
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive